ONC
BeOne Medicines AG trades as ONC and has a market capitalization of $32.14 B, making it the #447 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $5.34B, up 40.2% from the prior year and net income of $286.93M. This page tracks BeOne Medicines AG through 1,165 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years BeOne Medicines AG's revenue grew from $1.07M to $5.34B, a compound annual growth rate of 157.6%. Net profit margin expanded from -11141.8% to 5.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider trade | 4 | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| 3/A | - | 2026-05-15 |
Total revenue for the first quarter of fiscal 2025 increased approximately 12% to $4.8 million as compared to $4.3 million during the first quarter of fiscal ...
Mr. Gibson, 55, is the former Chief Financial Officer of Citra Health Solutions and Vivex Biomedical, Inc.
MDaudit will acquire all outstanding shares of Streamline stock for $5.34 per share in cash, which represents a premium of 138% to Streamline's closing price.
The largest companies sharing BeOne Medicines AG's SEC industry classification (pharmaceutical preparations).
BeOne Medicines AG (ONC) has a market capitalization of $32.14 B as of 2026-05-29, ranking #447 among US-listed companies.
BeOne Medicines AG reported revenue of $5.34B for fiscal year 2025, an increase of 40.2% year over year.
Yes. BeOne Medicines AG reported net income of $286.93M in its latest fiscal year.